Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the <i>ATM</i> Gene

Abstract

This multicenter cohort study found that individuals with a germline pathogenic ATM variant were at an increased lifetime risk of pancreatic cancer. These risk estimates can help guide decision-making when evaluating the risks and benefits of enhanced early detection surveillance.